Sorrento Therapeutics Inc (NASDAQ:SRNE)

7.85
Delayed Data
As of May 25
 -0.10 / -1.26%
Today’s Change
1.50
Today|||52-Week Range
10.65
+106.58%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close7.95
Today’s open7.90
Day’s range7.70 - 8.20
Volume1,729,252
Average volume (3 months)3,241,636
Market cap$696.2M
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+1,762.81%
P/E ratio60.4
Price/Sales1.76
Price/Book3.12

Competitors

 Today’s
change
Today’s
% change
MTNBMatinas BioPharma Ho...-0.02-3.64%
VTLVital Therapies Inc-0.45-7.32%
--Verona Pharma PLC+0.00+0.32%
PRQRProQR Therapeutics N...-0.15-2.48%
Data as of 8:00pm ET, 05/25/2018

Financials

Next reporting dateMay 28, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$151.9M
Annual profit (last year)$9.1M
Net profit margin5.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Henry H. Ji
Chief Financial Officer &
Executive Vice President
Jiong Shao
Corporate headquarters
San Diego, California

Forecasts